Pulmonary hypertension in chronic lung disease and hypoxia
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated with reduced functional ability, impaired quality of life, greater oxygen requirements and an increased risk of mortality. The aetiology of CLD-PH is complex and multifactorial, with differences in the pathogenic sequelae between the diverse forms of CLD. Haemodynamic evaluation of PH severity should be contextualised within the extent of the underlying lung disease, which is best gauged through a combination of physiological and imaging assessment. Who, when, if and how to screen for PH will be addressed in this article, as will the current state of knowledge with regard to the role of treatment with pulmonary vasoactive agents. Although such therapy cannot be endorsed given the current state of findings, future studies in this area are strongly encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The OPTN/UNOS registry data demonstrate that Group 3 pulmonary hypertension is common in patients with advanced CF, ILD, and COPD and is associated with increased oxygen requirements and increased mortality.(294–299)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [294]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Self-citationSildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Self-citationSevere Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Consensus Statement on Chronic and Subacute High Altitude Diseases
León-Velarde, F., Maggiorini, M., Reeves, J. T., Aldashev, A., Asmus, I., Bernardi, L., Ge, R.-L., Hackett, P., Kobayashi, T., Moore, L. G., et al. (2005) · High Altitude Medicine & Biology · doi:10.1089/ham.2005.6.147 · Cited by 630
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationKESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B., & WEITZENBLUM, E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803117 · Cited by 549
Obesity-Associated hypoventilation in hospitalized patients: prevalence, effects, and outcome
Nowbar, S., Burkart, K. M., Gonzales, R., Fedorowicz, A., Gozansky, W. S., Gaudio, J. C., Taylor, M. R. G., & Zwillich, C. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.022 · Cited by 512
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M., Beghetti, M., Humpl, T., Raskob, G. E., Ivy, D. D., Jing, Z.-C., Bonnet, D., Schulze-Neick, I., & Barst, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 508
Cited by
Items 701–800 of 834
Predictors of pulmonary hypertension in patients with hypersensitivity pneumonitis
Трушенко, Н. В., Levina, I. A., Suvorova, O., Nekludova, G. V., Tsareva, N. A., Volkov, A. V., Мержоева, З. М., Kulaeva, M. A., & Avdeev, S. N. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-507
Rosenkranz, S. (2025) · Springer eBooks · doi:10.1007/978-3-662-69938-6_30
Genecand, L. (2023) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:170488
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682151
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682136
Suraya, R., Nagano, T., Ryanto, G. R. T., Effendi, W. I., Hazama, D., Katsurada, N., Yamamoto, M., Tachihara, M., Emoto, N., Nishimura, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20166809
Weiss, T., Near, A. M., Zhao, X., Ramey, D. R., Banerji, T., Xie, H., & Nathan, S. D. (2024) · Figshare · doi:10.6084/m9.figshare.24604011
Self-citationKashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682157
Suraya, R., Nagano, T., Ryanto, G. R. T., Effendi, W. I., Hazama, D., Katsurada, N., Yamamoto, M., Tachihara, M., Emoto, N., Nishimura, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20166806
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682169
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682127
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682166
Benjamin, N. (2023) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00032713
強皮症並びに関節リウマチの病態評価および病態解明に関する研究
蜷川, 慶. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14943/doctoral.k14970
Die Rolle der microRNA-100 in der pulmonalen Hypertonie
Schmitz, V. (2021) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.27889
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682142
Milara, J., Roger, I., Montero, P., Artigues, E., Escrivá, J., & Cortijo, J. (2022) · Figshare · doi:10.6084/m9.figshare.21557696
Weiss, T., Rosen Ramey, D., Yang, L., Liu, X., Patel, M. J., Rajpathak, S. N., Bajwa, E. K., & Lautsch, D. (2022) · Figshare · doi:10.6084/m9.figshare.21358101
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682118
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682139
Elnady, M. A., Elkorashy, R. I., Nabil, A., & Ibrahim, E. K. (2024) · Figshare · doi:10.6084/m9.figshare.26567432
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682154
Milara, J., Roger, I., Montero, P., Artigues, E., Escrivá, J., & Cortijo, J. (2022) · Figshare · doi:10.6084/m9.figshare.21557702
Haberer, J., & Justus Liebig University Giessen (2019) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-14816
Walthelm-Hösel, J. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-31439
Risk assessment in pulmonary hypertension
Stubbs, H. D. (2024) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.84813
Wade, R. C., Mkorombindo, T., Ling, S. X., Helgeson, E. S., MacDonald, D. M., Pew, K., Voelker, H. T., Bittner, V., Kunisaki, K. M., Lammi, M. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24540701
Ma, L., Wang, Y., Li, X., Wang, Z., Zhang, B., Luo, Y., Wu, Y., Li, Z., & Niu, W. (2023) · Figshare · doi:10.6084/m9.figshare.24804295
Gayen, S. K., Zulty, M., & Criner, G. J. (2024) · Figshare · doi:10.6084/m9.figshare.26677946
Sassmann, T., Douschan, P., Foris, V., Tröster, N., Zeder, K., Brcic, L., Tornyos, A., Bachmaier, G., Fuchsjäger, M., Olschewski, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26551906
Self-citationWeiss, T., Near, A. M., Zhao, X., Ramey, D. R., Banerji, T., Xie, H., & Nathan, S. D. (2024) · Figshare · doi:10.6084/m9.figshare.26643274
Self-citationHarbaum, L., Hennigs, J. K., Simon, M., Oqueka, T., Watz, H., & Klose, H. (2021) · Figshare · doi:10.6084/m9.figshare.14926736
The role of PINK1-dependent mitophagy for development of pulmonary hypertension
Saraji, A. A., & Justus Liebig University Giessen (2021) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-14942
Risk Assessment in Severe PH Due to ILD– A Cross Sectional Study
Ravi Kumar, P., & N., H. G. (2024) · International Journal of Pharmaceutical and Clinical Research · doi:10.5281/zenodo.14052409
Comparison of DLCO and Spirometry for Monitoring of Disease in Patients of ILD
Sofi, A. A., Khan, Z., & Malik, J. A. (2024) · International Journal of Pharmaceutical and Clinical Research · doi:10.5281/zenodo.14246199
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682121
Milara, J., Roger, I., Montero, P., Artigues, E., Escrivá, J., & Cortijo, J. (2022) · Figshare · doi:10.6084/m9.figshare.21557699
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682124
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682148
Weiss, T., Near, A. M., Zhao, X., Ramey, D. R., Banerji, T., Xie, H., & Nathan, S. D. (2023) · Figshare · doi:10.6084/m9.figshare.24603684
Self-citationKashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682160
Abu, T., Levi, A., Hasdai, D., Kramer, M. R., Bental, T., Bdolah‐Abram, T., Shiyovich, A., Samara, A., Assa, H. V., Perl, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19185826
Πνευμονική υπέρταση στην καρδιακή ανεπάρκεια
Σαραντάρη, Κ. Λ. (2023) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.38876
Suraya, R., Nagano, T., Ryanto, G. R. T., Effendi, W. I., Hazama, D., Katsurada, N., Yamamoto, M., Tachihara, M., Emoto, N., Nishimura, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20166812
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682130
Abu, T., Levi, A., Hasdai, D., Kramer, M. R., Bental, T., Bdolah‐Abram, T., Shiyovich, A., Samara, A., Assa, H. V., Perl, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19185823
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682163
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682133
Kashiwada, T., Tanaka, Y., Tanaka, T., Okano, T., Saito, Y., Seike, M., Hino, M., Kimura, H., & Gemma, A. (2024) · Figshare · doi:10.6084/m9.figshare.26682145
Alqarni, A. A. M. (2020) · Nottingham ePrints (University of Nottingham)
Araújo, P. C. D. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Dignam, J. P. (2023) · Queen Mary Research Online (Queen Mary University of London)
View or download the full issue
Sciences, J. O. T. M. (2023) · Jurnal Perlindungan Tanaman Indonesia (Universitas Gadjah Mada)
Fiedler, D. (2023) · Common Library Network (Der Gemeinsame Bibliotheksverbund)
Maldonado-Velez, G. (2024) · IUScholarWorks (Indiana University) · doi:10.7912/mz8v-fz05
Charakterisierung und klinisches Management von Patienten mit Pulmonaler Hypertonie
Barnikel, M. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.36258
Pulmonary Hypertension Complicating Interstitial Lung Disease: Current Concepts and Controversies
King, C. S., & Thomas, C. (2025) · Respiratory medicine · doi:10.1007/978-3-032-03581-3_9
Piccari, L., BALASUBRAMANIAN, A., Khilzi, K., Lichtblau, M., & Rodriguez, D. A. (2025) · Respiratory medicine · doi:10.1007/978-3-032-03581-3_8
Pulmonary Vascular Disease Associated with Other Parenchymal Lung Diseases
Louw, E. H., van Heerden, J. K., Buckley, A., & Allwood, B. (2025) · Respiratory medicine · doi:10.1007/978-3-032-03581-3_12
RV/PA Coupling in Pulmonary Hypertension Secondary to Chronic Lung Disease
Zeba, F., Heerdt, P. M., & Singh, I. (2025) · Respiratory medicine · doi:10.1007/978-3-032-03581-3_7
Altınsoy, M., Çelik, D., Bozduman, F., Ergün, P., Kurt, H. G., Bulut, S., Baykal, H., & Güllü, Y. T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020437
Herbert, S., Dimopoulos, K., Jenkin, I., Dawes, T. J. W., Bax, S., McCabe, C., Nashat, H., Mukherjee, B., Rawal, B., Wells, A. U., et al. (2026) · ERJ Open Research · doi:10.1183/23120541.01231-2025
Ding, S., Chen, J., Li, Z., Yu, Y., Wang, W., Liao, Y., Yang, J., Lu, D., & Fan, Y. (2026) · Cell Proliferation · doi:10.1111/cpr.70179
Bajwa, E. K., Cislak, D., Palcza, J. S., Reynders, T., Barthson, J., Rottey, S., Lai, E., & Stoch, S. A. (2026) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.70035
Current perspectives on imaging modalities in the diagnosis and management of pulmonary hypertension
Yamamoto, S., & Sakamaki, F. (2026) · Respiratory Investigation · doi:10.1016/j.resinv.2026.101389
Ni, J., Xu, P., & Lu, W. (2026) · International Journal of COPD · doi:10.2147/copd.s563591
Caton, T., Pescatore, J., NARANJO, M., & Gayen, S. K. (2026) · BMC Pulmonary Medicine · doi:10.1186/s12890-026-04203-4
Raza, A., Rali, P., Naranjo-Tovar, M., & Gayen, S. K. (2026) · CHEST Pulmonary · doi:10.1016/j.chpulm.2026.100244
Robertsson, H. J. (2024) · Lithuanian University of Health Sciences
Early diagnosis of pulmonary hypertension and its peculiarities
Idzelytė, I., & Slapšytė, K. (2020) · Lithuanian University of Health Sciences
Ayachi, N., Mekki, S., & Bendimered, S. M. (2019) · Dépôt Institutionnel de lUniversité de Tlemcen
Beatrix, N. Á. (2023) · Pesci Egyetemi Archivum (University of Pécs)
Pulmonary Hypertension Associated With COVID‐19 Interstitial Lung Disease
Mehta, S., Herbert, S., Dimopoulos, K., Rawal, B., Garfield, B. E., Heightman, M., Myall, K., Mukherjee, B., Harries, C., Nashat, H., et al. (2026) · Pulmonary Circulation · doi:10.1002/pul2.70281
Kaya, K., Uçar, A., Dizaji, A. N., Güzel, F. D., & Kozacı, L. D. (2026) · Eskişehir Technical University Journal of Science and Technology A - Applied Sciences and Engineering · doi:10.18038/estubtda.1737583
Okaya, T. (2024) · Institutional Repositories DataBase (IRDB) · doi:10.20776/900122840
Ren, Q., Yi, Y., & Li, S. (2026) · The Analyst · doi:10.1039/d6an00373g
Hulaimi, H., Yanti, B., Arliny, Y., Ridwan, M. Q., Nurrahmah, N., & Yanifitri, D. B. (2026) · Heart Science Journal · doi:10.21776/ub.hsj.2026.007.02.12
Gómez, C. K. F., Tuta-Quintero, E., Bastidas, A. R., Forero, A. L., González, M. D. N., Márquez, V. O., Pérez, M. J. H., Leal, A. C. C., Rodríguez, M. M., Sánchez, J. C. R., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093365
Dotsenko, S. Y., Dotsenko, M. Y., Кулинич, Р. Л., Кошля, О. В., & Шевченко, М. В. (2026) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2026.2.350884
Emerging role of DYRK1A as a target in cardiovascular diseases (Review)
Yu, L., Cheng, Q., & Wu, J. (2026) · Molecular Medicine Reports · doi:10.3892/mmr.2026.13903
Imani, S. (2026) · VTechWorks (Virginia Tech)
Laz, N. I., Hussein, F. G. M., Mohammad, M. F., Ali, D. A., & Arafat, W. R. (2026) · Egyptian Journal of Bronchology · doi:10.1186/s43168-026-00568-6
Nuthalapati, D., Arun, K., Venkateshan, A., & Perrin, M. E. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.32s.75
Lopez, E. K., Geller, A., LEGUIZAMON, R., Lam, J., Srikulmontri, T., Ricaurte, M. V., de Melo, M. S. T., Stavola, T., Malin, J. H., Lo, K. B., et al. (2026) · Pulmonary Circulation · doi:10.1002/pul2.70328
Use of Anticoagulants as a Supportive Measure in Pulmonary Hypertension: A Narrative Review
Les, O., Aghabekyan, T., Bhamidipati, D., Belligund, P. M., Geraghty, P. M., Panduranga, V. T., McFarlane, S., & John, S. (2026) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2026.0047
Variational Consensus Monte Carlo for Bayesian MixturePreprint
Fendler, J., Crowe, F. L., Marshall, T., Richardson, S. T., & Kirk, P. (2026) · arXiv (Cornell University) · doi:10.48550/arxiv.2606.19643
Evolution of Exercise Training in Patients with Pulmonary Hypertension—A Comprehensive Review
Beis, I., Δίπλα, Κ., Boutou, A., Zacharias, A., Pataka, A., Sourla, E., Zafeiridis, A., & Pitsiou, G. (2026) · Healthcare · doi:10.3390/healthcare14121796
Deteksi Hipertensi Paru pada Penyakit Paru Kronik: Tinjauan Pustaka
Putra, M. R. A., & Nurwidya, F. (2026) · Journal Of The Indonesian Medical Association · doi:10.47830/jinma-vol.76.1-2026-2036
The SAVOIR study: protocol for the development and validation of a PAH knowledge questionnaire
Nascimento, I. A. D. O., de Carvalho, G. G., Rossetto, N. Z., Cauzzo, I. S., Milan, M. M., Jardim, C., & Fernandes, C. J. C. D. S. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.109028
Diwakar, S. K., & Rastogi, R. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.67s.93
Smukowska-Gorynia, A., Iwańczyk, S., Ciurzyński, M., Waligóra, M., Kurzyna, M., Pruszczyk, P., Kopeć, G., Mizia‐Stec, K., Skoczylas, I., Chrzanowski, Ł., et al. (2026) · Pulmonary Circulation · doi:10.1002/pul2.70370
ERİNÇ, A., Kirac, A., Gul, S., & Çetınkaya, E. (2026) · Comprehensive Medicine · doi:10.14744/cm.2026.83723
Reccardini, N., Re, B. D., Mondini, L., Salton, F., Confalonieri, M., Confalonieri, P., Hughes, M., Monteleone, G., & Ruaro, B. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1865787
Nagelschmitz, J., Saleh, S., Ligges, S., Seidel-Greven, M., Becker‐Pelster, E., Nikkho, S. M., Boxnick, S., & Wj, T. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70668
Pulmonary rehabilitation in COPD with suspected pulmonary hypertension: a step toward
Mismetti, V., Montani, D., & Bertoletti, L. (2026) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2026.101309
Okwah, M. N., Ihesiulo, A., Adepoju, J. M., Abhulimen, I. J., Adolalom, O., Oladeji, O., Akinrele, O. R. A., Ihesiulo, C., Asif, A., Bajpai, S. K., et al. (2026) · Journal of Respiration · doi:10.3390/jor6030018
Navigating the Complexity of PH-ILD: From Molecular Mechanisms to Integrated Clinical Evaluation
Vasarmidi, E., Calaras, D., Kourouni, I., Perelas, A., & Antoniou, K. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27157055
Metadata
- Authors
- Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., Weissmann, N., & Seeger, W.
- Affiliations
- Inova Fairfax Hospital (US)
- MultiMedica (IT)
- Medical University of Graz (AT)
- Medizinische Hochschule Hannover (DE)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Justus-Liebig-Universität Gießen (DE)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801914
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351338
- OpenAlex
- W2904463477
- Cited by
- 757
- References
- 94
- Citations by year
- 2026: 54 · 2025: 104 · 2024: 141 · 2023: 96 · 2022: 122 · 2021: 114 · 2020: 76 · 2019: 44
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc)
- Funders
- American Thoracic Society
- Pfizer
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- United Therapeutics Corporation
- Sunovion
- Veracyte
- York University
- National Institutes of Health
- Genentech
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- pulmonary hypertension, chronic lung disease, hypoxia, hemodynamic assessment, quality of life, mortality risk, oxygen requirement
- MeSH terms
- Animals, Hypoxia, Antihypertensive Agents, Chronic Disease, Humans, Hypertension, Pulmonary, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.